Mandy van Gulijk

1.0k citations
7 papers · 149 indexed · h-index 6
Topics
Cancer Immunotherapy and Biomarkers (6 papers)CAR-T cell therapy research (3 papers)Occupational and environmental lung diseases (2 papers)

In The Last Decade

Mandy van Gulijk

7 papers receiving 148 citations

Peers

Mandy van Gulijk
Comparison fields: 5 of 42
  • Oncology 94
  • Immunology 94
  • Pulmonary and Respiratory Medicine 27
  • Molecular Biology 23
  • Genetics 17
Replace Lloyd Bod with:
Lloyd Bod United States
Jessica S.W. Borgers Netherlands
Jessica Mariel Sierra Argentina
Adriana Petrazzuolo France
Ángela Fernández de Lascoiti Spain
Iris Wang United States
Anne Calvez France
Fernando Henao Spain
Layton Woolford United States
Anna‐Sophia Wiekmeijer Netherlands
Mandy van Gulijk relative to Lloyd Bod United States Lloyd Bod's profile →
Citations per field
00.5×1.5×2.1×
Lloyd Bod · 1×
Citations per year

Countries citing papers authored by Mandy van Gulijk

Since Specialization
Citations

This map shows the geographic impact of Mandy van Gulijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mandy van Gulijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mandy van Gulijk more than expected).

Fields of papers citing papers by Mandy van Gulijk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mandy van Gulijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mandy van Gulijk. The network helps show where Mandy van Gulijk may publish in the future.

Co-authorship network of co-authors of Mandy van Gulijk

This figure shows the co-authorship network connecting the top 25 collaborators of Mandy van Gulijk. A scholar is included among the top collaborators of Mandy van Gulijk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mandy van Gulijk. Mandy van Gulijk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 7
2 5
3 38
4 22
5 2
6 57
7 18

About Mandy van Gulijk

Mandy van Gulijk is a scholar working on Oncology, Immunology and Biotechnology, having authored 7 papers that have together received 149 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), CAR-T cell therapy research (3 papers) and Occupational and environmental lung diseases (2 papers). The work is most often cited by research in Immunology (94 citations), Oncology (94 citations) and Genetics (17 citations). Mandy van Gulijk has collaborated with scholars based in Netherlands, Austria and Germany. Frequent co-authors include Joachim G.J.V. Aerts, Floris Dammeijer, Heleen Vroman, Gregor Sturm, Sjoerd H. van der Burg, Szymon M. Kiełbasa, Christianne Groeneveldt, Marjolein Sluijter, Saskia J. Santegoets and Pornpimol Charoentong. Their work appears in journals such as International Journal of Cancer, Frontiers in Immunology and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026